Novel 1, 3, 4-Oxadiazole-pyridine hybrids as potential DNA gyrase B inhibitors (5D7R): ADMET prediction and molecular docking study
Abstract
A small molecule (ligand) is placed in the binding site of its macromolecular target (receptor) using a computational process called molecular docking, which also calculates the binding affinity of the small molecule. With the use of PyRx software, the current study tried a high-throughput in-silico screening of 16 compounds docked with the crystal structure of DNA gyrase B receptors (PDB ID: 5D7R). In the range of -8.0 and -8.1, 3 of these 16 compounds displayed very good mol dock scores. As a typical medicine, amoxicillin medications have a mol dock score of -7.1. According to the results, all of the investigated ligands occupy similar positions and directions within the putative binding site of DNA gyrase B receptors (PDB ID: 5D7R), which reveals a sizable area surrounded by a membrane binding domain that acts as a pathway for substrate entry into the active site. Additionally, any small molecule's affinity can be viewed as a special instrument in the field of drug design and provide a possibility for future study to create an antibacterial activity. Additionally, ADME evaluations must be used to confirm compounds that are candidates for oral administration. The findings demonstrated that compound 4a, 4b, 4c, 4d, 4i, 4j, and 4k absorbed from GIT and compound 4i, 4j, and 4k fulfilled the Lipinski rule.
Keywords: 1, 3, 4-Oxadiazole, ADME Evaluation, molecular docking, antimicrobial activity
Keywords:
1, 3, 4-Oxadiazole, ADME Evaluation, molecular docking, antimicrobial activityDOI
https://doi.org/10.22270/jddt.v13i3.5749References
Sliwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods in drug discovery. Pharmacological reviews. 2014 Jan 1; 66(1):334-95. https://doi.org/10.1124/pr.112.007336
Jangra S, Kumar S, Choudhary M. Molecular docking studies of 1, 3, 4 oxadiazoles Derivatives as anti-convulsive agents. World Journal of Advanced Research and Reviews. 2020; 8(1):151-79. https://doi.org/10.30574/wjarr.2020.8.1.0381
Yurttaş L, Bülbül EF, Tekinkoca S, Demirayak Ş. Antimicrobial activity evaluation of new 1,3,4-oxadiazole derivatives. Acta Pharm Sci. 2017; 55(2):45-54. https://doi.org/10.23893/1307-2080.APS.05511
Macaev, F.et al., R: Synthesis of Novel 5-aryl-2- thio-1,3,4-oxadiazoles and the Study of Their Structure-Anti-Mycobacterial Activities Bioorg Med Chem 2005; 13:4842. https://doi.org/10.1016/j.bmc.2005.05.011
Abd-Ellah SH, Abdel-Aziz M, Shoman ME, Beshr EAM, Kaoud TS, Ahmed ASFF. New 1,3,4- oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory and ulcerogenic liability. Bioorg Chem. 2017; 74:15- 29. https://doi.org/10.1016/j.bioorg.2017.06.003
Zou, X. J.; Lai, L. H.; Jin, G. Y.; Zhang, Z. X. Synthesis, Fungicidal Activity, and 3D-QSAR of Pyridazinone-Substituted 1,3,4-oxadiazoles and 1,3,4-thiadiazoles J Agric Food Chem 2002; 50:3757 https://doi.org/10.1021/jf0201677
Palaska E, Sahin G, Kelicen, P Durlu N. T, Altinok, G. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4- oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmacoterapia 2002; 57:101. https://doi.org/10.1016/S0014-827X(01)01176-4
Bajaj S, Roy PP, Singh J. Synthesis, thmynidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadizole-2-thione derivatives as a potential anticancer agent. Comput Biol Chem. 2018; 74:151-160. https://doi.org/10.1016/j.compbiolchem.2018.05.013
Ryng S, Zimecki M, Jezierska-Mazzarello A, Panek JJ, Mączyński M, et al. A complex study of 5-amino-3-methyl-4-[2-(5-amino-1,3,4- oxadiazolo)]-isoxazole monohydrate: A new low-molecular-weight immune response modifier. Journal of Molecular Structure 2011; 999:60-67. https://doi.org/10.1016/j.molstruc.2011.05.031
Zarghi A, Tabatabai S. A, Faizi M, Ahadian A, Navabi P, Zanqaneh V, Shafiee A. Z. Synthesis and Anticonvulsant Activity of New 2- substituted-5-(2-benzyloxyphenyl)-1,3,4- oxadiazoles. Bioorg Med Chem Lett 2005; 15:863 https://doi.org/10.1016/j.bmcl.2005.02.014
Khan M. T, Choudhary M. I, Khan K. M, Rani M, Atta‐ur‐Rahman. Structure-activity Relationships of Tyrosinase Inhibitory Combinatorial Library of 2,5-disubstituted-1,3,4- oxadiazole Analogues. Bioorg Med Chem 2005; 13:3385 https://doi.org/10.1016/j.bmc.2005.03.012
Ibrahim TS, Almalki AJ, Moustafa AH, Allam RM, Abuo-Rahma GE, El Subbagh HI, Mohamed MF. Novel 1, 2, 4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study. Bioorganic Chemistry. 2021 Jun 1; 111:104885. https://doi.org/10.1016/j.bioorg.2021.104885
Jadhav GR, Deshmukh DG, Medhane VJ, Gaikwad VB, Bholay AD. 2, 5-Disubstituted 1, 3, 4-oxadiazole derivatives of chromeno [4, 3-b] pyridine: Synthesis and study of antimicrobial potency. Heterocyclic Communications. 2016 Jun 1; 22(3):123-30. https://doi.org/10.1515/hc-2015-0215
Gaonkar SL, Rai KL, Prabhuswamy B. Synthesis and antimicrobial studies of a new series of 2-{4-[2-(5-ethylpyridin-2-yl) ethoxy] phenyl}-5-substituted-1, 3, 4-oxadiazoles. European journal of medicinal chemistry. 2006 Jul 1; 41(7):841-6. https://doi.org/10.1016/j.ejmech.2006.03.002
Farghaly AA, Vanelle P, El-Kashef HS. Synthesis, reactions and antimicrobial activity of some new 1, 3, 4-oxadiazoles, 1, 2, 4-triazoles and 1, 3, 4-thiadiazines derived from pyrazole. Heterocyclic Communications. 2005 Aug 1; 11(3-4):255-62. https://doi.org/10.1515/HC.2005.11.3-4.255
Aghekyan АА, Mkryan GG, Panosyan HA, Safaryan AS, Stepanyan HM. Synthesis and Antibacterial Activity of Novel (4-Methoxyphenyl)-tetrahydropyranyl-substituted 1, 3, 4-Oxadiazoles. Russian Journal of Organic Chemistry. 2020 Feb; 56:281-6. https://doi.org/10.1134/S1070428020020177
Bakavoli M, Rahimizadeh M, Shiri A, Eshghi H, Vaziri-Mehr S, Pordeli P, Nikpour M. Synthesis and evaluation of antibacterial activity of new derivatives of pyrimido [4, 5-e][1, 3, 4] oxadiazine. Heterocycl. Commun., 2011; 17(1-2):49-52. https://doi.org/10.1515/hc.2011.009
Ningaiah S, Bhadraiah UK, Doddaramappa SD, Keshavamurthy S, Javarasetty C. Novel pyrazole integrated 1, 3, 4-oxadiazoles: Synthesis, characterization and antimicrobial evaluation. Bioorganic & medicinal chemistry letters. 2014 Jan 1; 24(1):245-8. https://doi.org/10.1016/j.bmcl.2013.11.029
Published
Abstract Display: 368 
PDF Downloads: 459 PDF Downloads: 25 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.